📰 Options Segment News
Page 35 - Options Segment News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Options Segment. Real-time updates on events, politics, business and more.
February 1, 2024
Balachander Sekhar, Co-founder, RenewBuy
February 1, 2024
R Mukundan, MD and CEO, Tata Chemicals
February 1, 2024
Simon Wiebusch, President of Bayer South Asia and Vice Chairman, MD & CEO of Bayer CropScience
February 1, 2024
Rajani Sinha, Chief Economist at CareEdge Ratings
February 1, 2024
Fiscal deficit of 5.1% of GDP for FY25 is much better than the most optimistic expectations.
January 31, 2024
Weak performance expected from the company.
January 31, 2024
Recommendation: Buy; Target price: ₹340
January 31, 2024
Recommendation: Reduce; Target price: ₹11
January 31, 2024
Recommendation: Buy; Target price: ₹550
January 31, 2024
Recommendation: Reduce; Target price: ₹2,700